Cardiovascular Disease Early Detection and Prevention Act of 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
The bill changes federal law so that group health plans, individual insurers, Medicare and Medicaid must pay for lipoprotein(a) and apolipoprotein B blood tests without any cost‑sharing. It targets people with a family history of early heart disease, a prior heart attack or stroke, high LDL cholesterol, diabetes, obesity, or other recognized risk factors. The aim is to catch cardiovascular risk earlier, since heart disease is the leading cause of death in the United States.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 8260 changes status, plus AI-powered summaries and stage predictions.
Sign up free